1.What is LevofloxacinoTarbis Farmaand for what it is used
2.What you need to know before starting to take LevofloxacinoTarbis Farma
3.How to take LevofloxacinoTarbis Farma
4.Possible adverse effects
5.Storage of LevofloxacinoTarbis Farma
6.Contents of the package and additional information
The name of this medication is Levofloxacino Tarbis Farma. Levofloxacino Tarbis Farmacontains an active ingredient calledlevofloxacino. This belongs to a group of medicines called antibiotics. Levofloxacino is a type of antibiotic known as a quinolone, and it works by killing the bacteria that cause infections in your body.
LevofloxacinoTarbis Farmacan be used to treat infections in:
•The nasal passages
•The lungs, in people with long-term respiratory problems or pneumonia
•The urinary tract, including the kidneys or bladder
•The prostate, when the infection is persistent
•The skin and under the skin, including the muscles. This is sometimes referred to as “soft tissues”
In some special situations, LevofloxacinoTarbis Farmamay be used to reduce the risk of acquiring a type of lung infection called anthrax or a worsening of this disease after exposure to the bacteria that causes anthrax.
Before starting to take this medicine
Do not take antibacterial medicines that contain fluoroquinolones or quinolones, including Levofloxacino Tarbis Farma, if you have had a severe adverse reaction to a quinolone or fluoroquinolone in the past. If this is the case, inform your doctor as soon as possible.
Do not take this medicine and consult your doctor if:
Do not take this medicine if any of the above cases apply to you. In case of doubt, consult your doctor or pharmacist before taking Levofloxacino Tarbis Farma.
Warnings and precautions
Consult your doctor or pharmacist before taking your medicine if:
Consult an eye specialist immediately if you experience any changes in your vision or have any eye problems.
If you feel a strong and sudden pain in the abdomen, chest, or back, which may be symptoms of aortic dissection or aneurysm, go to the emergency department immediately. You may be at increased risk if you are receiving systemic corticosteroid treatment.
If you start experiencing sudden onset of shortness of breath, especially when lying down, or if you notice swelling in the ankles, feet, or abdomen, or the appearance of palpitations (sensation of rapid or irregular heartbeat), inform your doctor immediately.
Inform your doctor or pharmacist before taking levofloxacino if you are unsure whether any of the above cases apply to you.
Severe skin reactions
Severe skin reactions, including Stevens-Johnson syndrome, toxic epidermal necrolysis (TEN), and drug reaction with eosinophilia and systemic symptoms (DRESS), have been reported with the use of levofloxacino.
If you develop a severe skin rash or any of these skin symptoms, stop taking levofloxacino and contact your doctor or seek medical attention immediately.
Levofloxacino Tarbis Farma and other medicines
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medicine. This is because Levofloxacino Tarbis Farma may affect the functioning of other medicines. Additionally, some medicines may affect the functioning of Levofloxacino.
Particularly, inform your doctor if you are taking any of the following medicines, as it increases the likelihood of experiencing adverse effects when taking them with Levofloxacino Tarbis Farma:
Speak with your doctor if this applies to you.
Do not take Levofloxacino Tarbis Farma at the same time as the following medicines, as it may affect the way Levofloxacino Tarbis Farma works:
During treatment with this medicine
In rare cases, pain and swelling in the joints and inflammation or tendon rupture may occur. The risk is higher if you are an older person (over 60 years), have received an organ transplant, have kidney problems, or are receiving corticosteroid treatment. Joint inflammation and tendon rupture can occur in the first 48 hours of treatment and even several months after stopping Levofloxacino Tarbis Farma treatment. If you experience any pain or inflammation in a tendon (e.g., in the ankle, wrist, elbow, shoulder, or knee), stop taking Levofloxacino Tarbis Farma, contact your doctor, and keep the affected area at rest. Avoid any unnecessary exercise, as this may increase the risk of tendon rupture.
In rare cases, you may experience symptoms of nerve damage (neuropathy) such as pain, burning, tingling, numbness, and/or weakness, especially in the feet and legs or hands and arms. If this happens, stop taking Levofloxacino Tarbis Farma and inform your doctor immediately to prevent the development of a potentially irreversible condition.
Severe, prolonged, and potentially irreversible effects
Fluoroquinolone or quinolone-containing antibacterial medicines, including Levofloxacino Tarbis Farma, have been associated with rare but severe adverse effects, some of which were of long duration (persistent for months or years), incapacitating, or potentially irreversible. This includes tendon pain, muscle and joint pain in the upper and lower extremities, difficulty walking, abnormal sensations such as pins and needles, numbness, tingling, or burning (paresthesia), sensory disorders such as decreased vision, taste, smell, and hearing, depression, decreased memory, intense fatigue, and severe sleep disorders.
If you experience any of these adverse effects after taking Levofloxacino Tarbis Farma, contact your doctor immediately before continuing treatment. You and your doctor will decide whether to continue or not with the treatment, considering also the use of an antibiotic of another class.
Determination of opiates in urine
Urine tests may show “false positive” results for the presence of strong painkillers called “opioids” in patients taking Levofloxacino Tarbis Farma. Inform your doctor that you are taking Levofloxacino Tarbis Farma if they have prescribed a urine test.
Tuberculosis test
This medicine may cause a “false negative” result in some laboratory tests used to search for the bacteria that causes tuberculosis.
Pregnancy and breastfeeding
Do not take this medicine if:
•You are pregnant, may become pregnant, or think you may be pregnant.
•You are breastfeeding or plan to be.
Driving and operating machines
You may experience some adverse effects such as dizziness, drowsiness, balance disturbances (vertigo), or visual disturbances. Some of these adverse effects may affect your ability to concentrate or decrease your reaction time. If this occurs, do not drive or perform any work that requires high attention
Follow exactly the administration instructions of this medication as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
How to take this medication
•Take this medication by mouth
•Swallow the whole tablets with a little water
•The tablets can be taken during or between meals
If you are already taking iron tablets, zinc supplements, antacids, didanosine or sucralfate
Do not take these medications at the same time as Levofloxacino Tarbis Farma. You should take these medications at least two hours before or two hours after taking Levofloxacino Tarbis Farma.
What dose should you take
•Your doctor will decide how many Levofloxacino Tarbis Farma tablets you should take.
•The dose will depend on the type of infection you have and where the infection is located in your body.
•The duration of treatment will depend on the severity of your infection.
•If you think the effect of the medication is too weak or too strong, do not change the dose yourself, ask your doctor.
Adults and elderly patients
Upper respiratory tract infection
•Take two Levofloxacino Tarbis Farma 250 mg tablets once a day
•Or, take one Levofloxacino Tarbis Farma 500 mg tablet once a day
Lower respiratory tract infection, in people with long-term respiratory problems
•Take two Levofloxacino Tarbis Farma 250 mg tablets once a day
•Or, take one Levofloxacino Tarbis Farma 500 mg tablet once a day
Pneumonia
•Take two Levofloxacino Tarbis Farma 250 mg tablets once or twice a day
•Or, take one Levofloxacino Tarbis Farma 500 mg tablet once or twice a day
Urinary tract infection, including kidneys or bladder
•Take one or two Levofloxacino Tarbis Farma 250 mg tablets once a day
•Or, take half or one Levofloxacino Tarbis Farma 500 mg tablet once a day
Prostate infection
•Take two Levofloxacino Tarbis Farma 250 mg tablets once a day
•Or, take one Levofloxacino Tarbis Farma 500 mg tablet once a day
Skin and subcutaneous tissue infection, including muscles
•Take two Levofloxacino Tarbis Farma 250 mg tablets once or twice a day
•Or, take one Levofloxacino Tarbis Farma 500 mg tablet once or twice a day
Adults and elderly patients with kidney problems
Your doctor may possibly administer a lower dose.
Use in children and adolescents
This medication should not be administered to children or adolescents.
Protect your skin from the sun
Do not expose your skin directly to the sun (even on cloudy days) while taking this medication and for two days after stopping it, as your skin will become much more sensitive to the sun and may burn, itch, or even blister if you do not take the following precautions:
•Make sure to use high-protection sunscreens
•Always wear a hat and clothing that covers your arms and legs
•Avoid ultraviolet A (UVA) lamps
If you take more Levofloxacino Tarbis Farma than you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone: 91 562 04 20 indicating the medication and the amount used. The effects that may appear are: seizures (convulsions), confusion, dizziness, decreased consciousness, tremors, heart rhythm disturbances that may cause irregular heartbeats as well as nausea or heartburn.
If you forget to take Levofloxacino Tarbis Farma
If you forget to take a dose, take it as soon as you remember, unless it is almost time for your next dose. Do not take a double dose to compensate for the missed doses.
If you interrupt the treatment with Levofloxacino Tarbis Farma
Do not interrupt your treatment with Levofloxacino Tarbis Farma, even if you feel better. It is essential to complete the treatment course prescribed by your doctor. If you stop taking them too soon, the infection may recur, your condition may worsen, or the bacteria may become resistant to the medication.
If you have any other questions about the product, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them. They are usually mild to moderate and usually disappear in a short time.
Stop taking LevofloxacinoTarbis Farmaand contact a doctor or go to a hospital quickly if you notice the following side effects:
Very rare(may affect up to 1 in 10,000 people)
•If you have an allergic reaction. Symptoms may include: skin rash, difficulty swallowing or breathing, swelling of lips, face, throat, or tongue
Stop taking LevofloxacinoTarbis Farmaand contact a doctor immediately if you notice the following serious side effects, as you may need urgent medical treatment:
Rare(may affect up to 1 in 1,000 people)
Syndrome associated with water loss and low sodium levels (SIADH)
Very rare(may affect up to 1 in 10,000 people)
•Burning, tingling, pain, or numbness. These may be signs of what is called "neuropathy"
Unknown:(frequency cannot be estimated from available data)
•Loss of appetite, yellow skin and eyes, dark urine, itching, or stomach pain. These may be signs of liver problems that may include fulminant liver failure
Consult a specialist eye doctor if your vision worsens or you have any other eye problems while takingLevofloxacinoTarbis Farma.
Inform your doctor if any of the following side effects worsen or last more than a few days:
Frequent(may affect up to 1 in 10 people)
•Difficulty sleeping
•Headache, dizziness
•Uncomfortable feeling (nausea, vomiting) and diarrhea
•Increased levels of certain liver enzymes in the blood
Rare(may affect up to 1 in 100 people)
•Changes in the number of other bacteria or fungi, fungal infection by Candida, which may require treatment
•Changes in the number of white blood cells in blood test results (leucopenia, eosinophilia)
•Stress (anxiety), confusion, nervousness, drowsiness, tremors, sensation of dizziness (vertigo)
•Difficulty breathing (dyspnea)
•Changes in taste, loss of appetite, stomach upset or indigestion (dyspepsia), stomach pain, feeling bloated (flatulence) or constipation
•Itching and rash on the skin, intense itching or hives (urticaria), excessive sweating (hyperhidrosis)
•Joint or muscle pain
•Abnormal values in blood test results due to liver or kidney problems (elevated bilirubin or creatinine)
•Generalized weakness
Rare(may affect up to 1 in 1,000 people)
•Bleeding or bruising easily due to low platelet count (thrombocytopenia)
•Low white blood cell count (neutropenia)
•Exaggerated immune response (hypersensitivity)
•Low blood sugar (hypoglycemia). This is important for diabetic patients
•Seeing or hearing things that are not real (hallucinations, paranoia), changes in opinion and thoughts (psychotic reactions) with risk of suicidal thoughts or actions
•Depression, mental disorders, feeling restless (agitation), abnormal dreams or nightmares
•Numbness in hands and feet (paresthesias)
•Ear or eye problems (tinnitus or blurred vision)
•Abnormally fast heart rate (tachycardia) or low blood pressure (hypotension)
•Muscle weakness. This is important for people with myasthenia gravis (rare nervous system disease)
•Changes in kidney function and, occasionally, kidney failure that may be a result of an allergic reaction in the kidneys called interstitial nephritis
•Fever
Unknown ((frequency cannot be estimated from available data):
•Low red blood cell count (anemia): this may cause pale or yellow skin due to damage to red blood cells; low count of all types of blood cells (pancytopenia)
•Persistent fever, sore throat, and general feeling of illness. This may be due to low white blood cell count (agranulocytosis)
•Circulatory collapse (anaphylactic shock)
•High blood sugar (hyperglycemia) or low blood sugar that may lead to coma (hypoglycemic coma). This is important for diabetic patients
•Changes in sense of smell, loss of smell or taste (parosmia, anosmia, ageusia)
•Movement and gait disorders (dyskinesia, extrapyramidal disorders)
•Temporary loss of consciousness or posture (syncope)
•Temporary loss of vision, eye inflammation
•Ear or hearing problems
•Abnormally fast heart rate, irregular heart rhythm with life-threatening risk including heart stoppage, altered heart rhythm (denominated "prolongation of the QT interval", observed in the ECG, graphical representation of the heart's electrical activity)
•Difficulty breathing or wheezing (bronchospasm)
•Pulmonary allergic reactions
•Pancreatitis (inflammation of the pancreas)
•Hepatitis (inflammation of the liver)
•Sensitivity to sunlight and ultraviolet light (photosensitivity)
•Vasculitis (inflammation of blood vessels due to allergic reaction)
•Stomatitis (inflammation of the mucous membrane inside the mouth)
•Muscle breakdown and muscle destruction (rhabdomyolysis)
•Red and swollen joints (arthritis)
•Pain, including back, chest, and limb pain
•Porphyria crisis in patients with porphyria (rare metabolic disease)
•Persistent headache with or without blurred vision (benign intracranial hypertension)
The administration of antibiotics containing quinolones and fluoroquinolones has been associated with very rare cases of long-lasting or permanent adverse reactions (even months oryears) or permanent, such as tendon inflammation, tendon rupture, joint pain, limb pain, difficulty walking, abnormal sensations such as pinpricks, numbness, tingling, burning, or pain (neuropathy), depression, fatigue, sleep disorders, memory loss, and hearing, vision, taste, and smell loss, in some cases regardless of the presence of pre-existing risk factors.
Cases of aortic aneurysm and dissection, which could lead to rupture and be fatal, and heart valve insufficiency in patients who have received fluoroquinolones have been reported. See also section 2.
If you experience any side effect. Talk to your doctor or pharmacist. This includes any possible side effect not mentioned in this leaflet.
Reporting of adverse reactions:
If you experience any type of adverse reaction, consult your doctor or pharmacist, even if it is aside effect that does not appear in this leaflet. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use: https://www.notificaram.es. By reporting adverse reactions, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
This medication does not require special conservation conditions, but it is preferable to store Levofloxacino Tarbis Farma tablets in the original packaging in a dry place.
Do not use this medication after the expiration date that appears on the packaging and the blister after CAD. The expiration date is the last day of the month indicated.
Medications should not be disposed of through drains or in the trash. Dispose of the packaging and medications you no longer need at the SIGRE collection point of the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. In this way, you will help protect the environment.
Composition of LevofloxacinoTarbis Farma
Each tablet contains 500 mg of Levofloxacino as the active ingredient corresponding to 512.47 mg of levofloxacino hemihydrate.
The other components are:
Core: microcrystalline cellulose (PH 101), croscarmellose sodium, povidone (k-30), microcrystalline cellulose (PH 102), magnesium stearate.
Coating: hypromellose, titanium dioxide (E171), macrogol 400, iron oxide red (E172), iron oxide yellow (E172), polisorbate 80 (E433).
Appearance of the product and content of the container
Coated tablets with a yellow film, in the shape of a capsule, biconvex, scored on both sides, and with the code “I” on one side and “26” on the other side.
The tablets are supplied in Alu-PVC/Aclar blisters.
The 500 mg tablets are presented in containers of 1, 7, 14, and 500 tablets.
Only some container sizes may be commercially marketed.
Holder of the marketing authorization and responsible for manufacturing
Holder of the marketing authorization
Tarbis Farma S.L.
Gran Vía Carlos III, 94
08028 Barcelona
Spain
Responsible for manufacturing
Pharmadox Healthcare Ltd.
KW20A Kordin Industrial Park, Paola, PLA 3000
Malta
This medicine is authorized in the member states of the European Economic Area with the following names:
Portugal:Levofloxacina Hetero 500 mg coated tablets
Germany:Levofloxacin Hetero 500 mg Filmtabletten
Date of the last review of this leaflet:April 2022
The detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)www.aemps.gob.es
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.